SGIOF Shionogi & Co. Ltd

USD 53.50 0.00 0
Icon

Shionogi & Co. Ltd (SGIOF) Stock Analysis and Price Targets

COMMON STOCK | Drug Manufacturers - Specialty & Generic | OTC
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Slightly Bullish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 53.50

0.00 (0.00)%

USD 15.48B

N/A

N/A

N/A

Icon

SGIOF

Shionogi & Co. Ltd (USD)
COMMON STOCK | OTC
USD 53.50
0.00 0
Take a Tour
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Slightly Bullish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 15.48B

N/A

USD 53.50

Shionogi & Co. Ltd (SGIOF) Stock Forecast

N/A

Based on the Shionogi & Co. Ltd stock forecast from 0 analysts, the average analyst target price for Shionogi & Co. Ltd is not available over the next 12 months. Shionogi & Co. Ltd’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Shionogi & Co. Ltd is Slightly Bullish , which is based on 10 positive signals and 5 negative signals. At the last closing, Shionogi & Co. Ltd’s stock price was USD 53.50. Shionogi & Co. Ltd’s stock price has changed by +0.00% over the past week, +13.94% over the past month and +17.58% over the last year.

No recent analyst target price found for Shionogi & Co. Ltd
No recent average analyst rating found for Shionogi & Co. Ltd

Company Overview Shionogi & Co. Ltd

Shionogi & Co., Ltd. engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan. It offers Fetroja, a multidrug-resistant for gram-negative bacterial infection treatment; Cabenuva and Apretude an anti-...Read More

https://www.shionogi.com

1-8, Doshomachi 3-chome, Osaka, Japan, 541-0045

5,680

March

USD

USA

Adjusted Closing Price for Shionogi & Co. Ltd (SGIOF)

Loading...

Unadjusted Closing Price for Shionogi & Co. Ltd (SGIOF)

Loading...

Share Trading Volume for Shionogi & Co. Ltd Shares

Loading...

Compare Performance of Shionogi & Co. Ltd Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for SGIOF

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Shionogi & Co. Ltd (Sector: Drug Manufacturers - Specialty & Generic )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
ZTS
Zoetis Inc +2.84 (+1.71%) USD79.01B 34.04 22.84

ETFs Containing SGIOF

Symbol Name SGIOF's Weight Expense Ratio Price(Change) Market Cap

Frequently Asked Questions About Shionogi & Co. Ltd (SGIOF) Stock

Stock Target Advisor's fundamental analysis for Shionogi & Co. Ltd's stock is Slightly Bullish .

SGIOF stock's dividend yield is 2.07%. Our analysis grades SGIOF stock's dividend yield at F. This means that SGIOF stock's dividend yield is above 38% of the stocks in the Drug Manufacturers - Specialty & Generic sector in the OTC exchange. Based on this SGIOF may be a poor dividend stock for its sector.

Unfortunately we do not have enough data on SGIOF's stock to indicate what its average analyst target is.

SGIOF stock's Price/Earning ratio is 14.94. Our analysis grades SGIOF stock's Price / Earning ratio at F. This means that SGIOF stock's Price/Earning ratio is above 62% of the stocks in the Drug Manufacturers - Specialty & Generic sector in the OTC exchange. Based on this SGIOF may be a overvalued for its sector.

The last closing price of SGIOF's stock was USD 53.50.

The most recent market capitalization for SGIOF is USD 15.48B.

Unfortunately we do not have enough analyst data on SGIOF's stock to indicate whether its price will go up or not.

We can't find any ETFs which contains Shionogi & Co. Ltd's stock.

As per our most recent records Shionogi & Co. Ltd has 5,680 Employees.

Shionogi & Co. Ltd's registered address is 1-8, Doshomachi 3-chome, Osaka, Japan, 541-0045. You can get more information about it from Shionogi & Co. Ltd's website at https://www.shionogi.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...